Clinical Trial Update: BnH-015B Clinical Trial in Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

This clinical trial update notes that the Phase 1 study of BnH-015B for moderate Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BnH-015B

Snippet

Sponsor: BnH Research | Conditions: Alzheimer Disease | Phase 1 | Status: RECRUITING